DEA’s June 26 Deadline: What M-Dispensaries Should Know
By the Baghoomian Law team
California medical cannabis dispensaries are running a federal compliance clock most operators have never had to think about. As a result of the Drug Enforcement Administration’s expedited registration pathway for state-licensed medical operators, the practical deadline for dispensaries to lock in interim operating protection is roughly five weeks away. Operators who do not file by June 26, 2026 will lose the legal cover the DEA’s Final Order created and will face a more conventional, slower, and riskier path to federal registration.
What Actually Opened in April
The DEA’s April 23, 2026 Final Order, implementing the federal rescheduling of medical marijuana to Schedule III, also created a narrow expedited registration window for state medical licensees under 21 C.F.R. Section 1301.13(k). The DEA opened the application portal in late April. According to the agency’s own materials, dispensary applicants who submit within 60 days of the rescheduling will receive a decision within six months and may continue operating under their state license while the application is pending.
That 60-day window closes on June 26, 2026. Operators who file after that date will not lose access to federal registration outright, but they will no longer be protected by the DEA’s interim operating provision, and the agency has not committed to any specific processing timeline for late filings.
A few practical details that have surprised operators reviewing the portal for the first time: the only payment method the DEA currently accepts is PayPal, the annual registration fee is $794.00, and the expedited pathway is currently open to dispensaries only. The DEA has not yet released the parallel forms for medical cannabis manufacturers, cultivators, distributors, or analytical laboratories, and the drug codes operators must select on the application (7362, 7353, and 7386 depending on activity) are not intuitive for first-time DEA registrants.
Who Actually Qualifies in California
The expedited pathway is available only to operators authorized under a state medical license. In California, that means holders of an M-designated retail license from the Department of Cannabis Control (DCC). Operators with adult-use-only (A-designated) retail licenses do not currently qualify, because the rescheduling order applies only to marijuana sold under state medical authorization.
That distinction matters because most California retailers historically chose A-designation, M-designation, or dual designation based on tax and operational considerations that had nothing to do with federal law. The DCC’s recent procedural reforms have eased the process of adding or switching to an M-designation, but operators starting from an A-only license still need DCC approval of a designation change before they can file with the DEA. The state-side approval is not instantaneous, and operators who hope to make the June 26 window need to start the Form 27 designation change process now, not in early June.
The Per-Location Trap
One frequently overlooked feature of the expedited pathway is that DEA registration is tied to each principal place of business. A retailer with three M-designated storefronts in California needs three separate DEA registrations, three separate filings, and three separate fees. Multi-location operators frequently underestimate the administrative lift this creates: each location needs its own application package, its own diversion-control documentation, and its own responsible-individual designation.
Operators planning to add new locations after June 26 should also recognize that the expedited treatment is keyed to the location in operation at the time of application. A new dispensary opened in August will need to register on the post-window timeline regardless of whether the parent company already holds DEA registrations for other locations.
The Public-Interest Assessment
Even within the expedited pathway, federal registration is not a rubber stamp. Under 21 U.S.C. Section 823, the DEA must determine that registration is consistent with the public interest before granting it. The agency’s analysis under that statute considers diversion controls, compliance with state and local law, prior criminal history, and the applicant’s experience with controlled-substance handling.
The most consequential factor for most California operators is compliance with state and local law. A clean DCC compliance history weighs heavily in favor of approval. Conversely, open enforcement matters, recent disciplinary actions, or unresolved local permit disputes can drive a denial, and a denial creates a federal record that is, in most cases, more damaging than not having applied. Operators with active or recent DCC matters should treat the registration question as a strategic decision, not a procedural one, and should usually resolve the state issues first.
A second practical consideration is that the DEA application requires disclosure of criminal history and controlled-substance handling experience. Operators whose responsible-individual designations include parties with prior cannabis convictions, even cleared convictions under California’s expungement programs, should understand exactly how the federal disclosure rules apply before filing.
The Suspension Linkage Operators Are Underestimating
Possibly the most consequential feature of the expedited DEA pathway is what happens after registration. DEA registrations issued through this process are tied to the underlying state license. If the M-license is suspended, revoked, expired, or surrendered, the DEA registration is automatically suspended in parallel.
That changes the stakes of routine administrative work at the DCC. Late renewals, contested ownership changes, and disputed enforcement matters now have direct federal consequences. A 60-day administrative suspension at the state level becomes a 60-day suspension of Schedule III status, with cascading effects on 280E tax treatment for the affected period and on banking relationships that may be conditioned on continuous federal registration.
For most operators, the practical implication is that the calendar discipline around state license renewals, historically a back-office task, needs to be elevated to a board-level compliance priority once a federal registration is in place. Renewal applications that have historically been filed at the last minute should be filed early. Ownership-change transactions that create even short DCC license gaps should be restructured to avoid the gap.
What This Means for Operators
For California M-designated dispensaries, the practical first step before June 26 is to inventory the locations in operation, confirm that each location’s DCC license is current and in good standing, and prepare a separate DEA application package for each principal place of business. Operators should also confirm that their responsible-individual designations are accurate and consistent across state and federal filings, because inconsistencies between DCC records and DEA applications are a common cause of processing delays.
For A-designated retailers considering whether to add an M-designation in order to access the expedited pathway, the realistic timing analysis is tight. A Form 27 designation change to the DCC is no longer renewal-bound and no longer requires new local authorization for an M-only switch or an A-plus-M addition, but DCC review still takes time. Operators who decide today to pursue an M-designation can reasonably expect to file with the DEA before the June 26 deadline, but only if the state process is started immediately and the DEA package is prepared in parallel.
For operators who conclude they cannot make the window, the rational alternative is not to file a rushed or incomplete application. A denial during the expedited window is worse than a clean filing on the regular timeline. The medical cannabis operator’s federal compliance landscape is going to remain in flux through the second half of 2026, and operators who use the next several months to clean up state compliance, finalize responsible-party designations, and prepare complete federal documentation will be in a stronger position than operators who file hastily.
If you are evaluating whether your California license footprint qualifies for the expedited DEA pathway, or you need help coordinating the DCC designation change with the federal application, Baghoomian Law works with cannabis operators on state and federal licensing strategy. Contact our team to discuss your specific situation before the window closes.
This post is for informational purposes only and does not constitute legal advice. Consult licensed counsel for advice on your specific situation.
